Correlation Between Immuneering Corp and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both Immuneering Corp and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immuneering Corp and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immuneering Corp and Cullinan Oncology LLC, you can compare the effects of market volatilities on Immuneering Corp and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immuneering Corp with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immuneering Corp and Cullinan Oncology.
Diversification Opportunities for Immuneering Corp and Cullinan Oncology
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Immuneering and Cullinan is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Immuneering Corp and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Immuneering Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immuneering Corp are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Immuneering Corp i.e., Immuneering Corp and Cullinan Oncology go up and down completely randomly.
Pair Corralation between Immuneering Corp and Cullinan Oncology
Given the investment horizon of 90 days Immuneering Corp is expected to generate 1.92 times more return on investment than Cullinan Oncology. However, Immuneering Corp is 1.92 times more volatile than Cullinan Oncology LLC. It trades about 0.01 of its potential returns per unit of risk. Cullinan Oncology LLC is currently generating about 0.02 per unit of risk. If you would invest 560.00 in Immuneering Corp on August 28, 2024 and sell it today you would lose (352.00) from holding Immuneering Corp or give up 62.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immuneering Corp vs. Cullinan Oncology LLC
Performance |
| Timeline |
| Immuneering Corp |
| Cullinan Oncology LLC |
Immuneering Corp and Cullinan Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immuneering Corp and Cullinan Oncology
The main advantage of trading using opposite Immuneering Corp and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immuneering Corp position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.| Immuneering Corp vs. Pmv Pharmaceuticals | Immuneering Corp vs. Cullinan Oncology LLC | Immuneering Corp vs. Enliven Therapeutics | Immuneering Corp vs. Larimar Therapeutics |
| Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |